Wrist Splint, Small, Left

Marsoni

M251S

$29.00

Get it in 3 business days with 1 day shipping. Friday, May 29

Wrist Splint, Small, Left8" Wrist Splint, Small, Left Wrist (1EA) Nylon lined foam material is soft and breathable Slip on design with three loop lock closures helps to achieve the desired level of compression Ideal for carpel tunnel syndrome, tendonitis and for mild sprains or strains Removable and adjustable aluminum palmer stay Available in right or left wrist styles Specifications: LATEX FREE Yes LENGTH INCHES 8 " MATERIAL Nylon Outer,Plush Foam Liner MAX CIRCUMFERENCE 6.

Easy Shipping

Quick Dispatch:

Your Wrist Splint, Small, Left orders ship within 1-2 business days.

Delivery Options:

Standard: 3-7 business days
Fast: 2-3 business days
Express: 1-2 business days

Order Tracking:

You'll receive a tracking link by email once your Wrist Splint, Small, Left ships.

Need Help?
Questions about Wrist Splint, Small, Left, sizing, or delivery? We're just an email away.

Live Shipping Estimates:
Enter your location at checkout to see available shipping methods and costs for Wrist Splint, Small, Left in your area.

Get Shipping Estimates

Country Zip/Postal Code

Exchange/Return Notes

We offer a 30-day return/exchange service after receiving.
Final sale items are not eligible for returns or exchanges.
To process your return/exchange, please contact us at [email protected]
Please click here for more details>>> Return & Exchange Policy

The shoes were as advertised. Marc Joseph (I hav 4 other pairs) are the perfect shoes for me with my physical needs. Additionally they are exceptionally comfortable and attractive. This pair I returned because they weren’t quite the right fit for me. They are, like my other Marc Joseph shoes, very well made and very attractive.

WAS THIS REVIEW HELPFUL?YesReportShare

Reviewed in the United States on February 19, 2026

Verified Purchase

Francisco G.

Lowell, US

★★★★★ 5

Premium feel

Size: 10, Color: Black

Very comfortable to wear.

WAS THIS REVIEW HELPFUL?YesReportShare

Reviewed in the United States on April 20, 2026